Eric Goralnick, MD, MS

Eric Goralnick, MD, MS

Principal Investigator, Global Mass Vaccination Site Collaborative

Eric Goralnick, MD, MS serves as the Principal Investigator to the Global Mass Vaccination Site Collaborative, the Medical Director at Access and Network Development at Brigham and Women’s Hospital, and Associate Professor of Emergency Medicine at Harvard Medical School. He is responsible for system wide efforts to prepare, mitigate, respond, and recover from disasters in addition to coordination of all outside hospital transfers to the Brigham Health system. He is an Associate Professor of Emergency Medicine at Harvard Medical School. He is the faculty lead for the Harvard Medical School Civilian Military Collaborative , the Brigham and Women’s Center For Surgery and Public Health emergency medicine initiatives, an IHI faculty member and a US veteran.

NEWS
CBS Boston: ‘We All Need To Step Up’: Boston Doctors Teach Ukrainians How To Treat Wounds Of War

Dr. Eric Goralnick featured on WBZ in Boston on his work at Brigham and Women’s Hospital to create training videos to treat trauma wounds in Ukraine.

Mar 7 2022
NEWS
New York Times: Mass vaccination sites in the United States are returning

Dr. Eric Goralnick in the New York Times on the return of mass vaccination sites.

Jan 10 2022
NEWS - Perspectives
Ariadne Labs’ Global Mass Vaccination Collaborative: A Q&A with Eric Goralnick and Margaret Ben-Or

In April 2021, just months after COVID-19 vaccines received emergency use authorization, Ariadne Labs and partners launched a major effort to get shots in arms – as many as possible, as quickly as possible. The founding premise of the Global Mass Vaccination Site Collaborative was that by exchanging information, techniques, and insights, those on the… Continue reading Ariadne Labs’ Global Mass Vaccination Collaborative: A Q&A with Eric Goralnick and Margaret Ben-Or

Dec 16 2021
NEWS - Press Release
Ariadne Labs Launches Global Mass Vaccination Site Collaborative

New collaborative offers mass vaccination sites an essential network to support 200 million vaccinations in 100 days BOSTON, Mass, April 20, 2021/ Ariadne Labs has launched the Global Mass Vaccination Site Collaborative to facilitate a rapid information exchange in order to broaden the impact of and safely deliver more COVID-19 vaccinations globally. The collaborative currently… Continue reading Ariadne Labs Launches Global Mass Vaccination Site Collaborative

Apr 20 2021